Developing a Virtual Equity Hub: Adapting the Tumor Board Model for Equity in Cancer Care.
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
05 07 2022
05 07 2022
Historique:
received:
21
12
2021
accepted:
04
03
2022
pubmed:
21
4
2022
medline:
8
7
2022
entrez:
20
4
2022
Statut:
ppublish
Résumé
We define cancer equity as all people having as the same opportunity for cancer prevention, treatment, and survivorship care. However, marginalized populations continue to experience avoidable and unjust disparities in cancer care, access to clinical trials, and cancer survival. Racial and ethnic minorities, and individuals with low socioeconomic status, Medicaid insurance, limited health literacy, disabilities, and mental health disorders are more likely to experience delays to cancer diagnosis and less likely to receive guideline-concordant cancer care. These disparities are impacted by the social determinants of health including structural discrimination, racism, poverty, and inequities in access to healthcare and clinical trials. There is an urgent need to develop and adapt evidence-based interventions in collaboration with community partners that have potential to address the social determinants of health and build capacity for cancer care for underserved populations. We established the Virtual Equity Hub by developing a collaborative network connecting a comprehensive cancer center, academic safety net hospital, and community health centers and affiliates. The Virtual Equity Hub utilizes a virtual tumor board, an evidence-based approach that increases access to multi-specialty cancer care and oncology subspecialty expertise. We adapted the tumor board model by engaging person-centered teams of multi-disciplinary specialists across health systems, addressing the social determinants of health, and applying community-based research principles with a focus on populations with poor cancer survival. The virtual tumor board included monthly videoconferences, case discussion, sharing of expertise, and a focus on addressing barriers to care and trial participation. Specifically, we piloted virtual tumor boards for breast oncology, neuro-oncology, and individuals with cancer and serious mental illness. The Virtual Equity Hub demonstrated promise at building capacity for clinicians to care for patients with complex needs and addressing barriers to care. Research is needed to measure the impact, reach, and sustainability of virtual equity models for patients with cancer.
Identifiants
pubmed: 35443045
pii: 6571484
doi: 10.1093/oncolo/oyac069
pmc: PMC9256021
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
518-524Subventions
Organisme : NCI NIH HHS
ID : K08 CA230185
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA006516
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press.
Références
JAMA Netw Open. 2019 Aug 2;2(8):e198562
pubmed: 31390030
JAMA Psychiatry. 2013 Feb;70(2):209-17
pubmed: 23247556
Hepatology. 2010 Sep;52(3):1124-33
pubmed: 20607688
Cancer. 2021 Dec 01;127(23):4464-4469
pubmed: 34379799
Breast Cancer Res Treat. 2021 May;187(1):197-206
pubmed: 33495917
Perspect Public Health. 2021 Jun 16;:1757913921994610
pubmed: 34130548
Oncologist. 2017 Nov;22(11):1374-1382
pubmed: 28559411
BMC Health Serv Res. 2020 Jan 31;20(1):73
pubmed: 32005232
Front Public Health. 2020 May 12;8:134
pubmed: 32478025
J Clin Oncol. 2019 Jun 20;37(18):1524-1528
pubmed: 30986118
Head Neck. 2020 Jun;42(6):1310-1316
pubmed: 32329958
J Psychiatr Res. 2015 Nov;70:28-32
pubmed: 26424420
Lancet Psychiatry. 2014 Oct;1(5):343-50
pubmed: 26360998
Oncologist. 2017 Sep;22(9):1094-1101
pubmed: 28706009
J Clin Oncol. 2018 Sep 13;:JCO1801132
pubmed: 30212297
Prev Chronic Dis. 2018 Jan 04;15:E02
pubmed: 29300695
Leuk Lymphoma. 2020 Dec;61(14):3351-3359
pubmed: 32967496
Int J Gynecol Cancer. 2020 Nov;30(11):1840-1841
pubmed: 32522773
Ann Surg Oncol. 2022 Feb;29(2):1271-1277
pubmed: 34655352
Lancet Oncol. 2008 Mar;9(3):222-31
pubmed: 18282806
Clin Infect Dis. 2021 Feb 16;72(4):703-706
pubmed: 32562416
Oncologist. 2019 Jul;24(7):901-910
pubmed: 30696722
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Ethn Dis. 2021 May 20;31(Suppl 1):357-364
pubmed: 34045837
Oncologist. 2016 Apr;21(4):467-74
pubmed: 26975867
Psychosom Med. 2014 Apr;76(3):215-20
pubmed: 24677164
Am Soc Clin Oncol Educ Book. 2014;:e461-6
pubmed: 24857140
Cancer. 2021 Jul 15;127(14):2399-2408
pubmed: 33899220
PLoS One. 2016 Jul 27;11(7):e0158013
pubmed: 27462907